HOME >> BIOLOGY >> NEWS
IBD (Crohn's, Colitis) 'joins' cancer, inflammatory diseases in associated blood vessel growth

Snowmass, Co. (September 13, 2004) Over at least the last decade it has been recognized that the growth of new blood vessels is critical in the pathogenesis of cancer because it increases blood supply to malignant tissue. Relatively recently, a novel pathogenic role of angiogenesis has been established for such chronic inflammatory diseases as rheumatoid arthritis, psoriasis and atherosclerosis.

As a result, suppressing neoangiogenesis is being investigated as a therapeutic approach for not only cancer, but also chronic inflammation.

Whether neoangiogenesis also occurs in Crohn's Disease (CD) and ulcerative colitis (UC), the major constituents of Inflammatory Bowel Diseases (IBD), has never been studied, according to the authors of a paper presented at an IBD translational conference sponsored by the American Physiological Society.

The paper is entitled, "Neoangiogenesis: a new component in Inflammatory Bowel Diseases pathogenesis."

Lead author Silvio Danese of Case Western Reserve University School of Medicine and Universita' Cattolica del S. Cuore, Rome, Italy, collaborated with colleagues Miquel Sans, Brenda Reyes-Rivera, Gail West, Homa Phillips, Joe Willis and Claudio Fiocchi at Case Western Reserve University School of Medicine; Carol de la Motte at the Cleveland Clinic Foundation; and Roberto Pola and Antonio Gasbarrini at Universita' Cattolica del S. Cuore.

According to Danese, "Our results show that increased vascularization is present in IBD, and the inflamed mucosal microenvironment actively promotes angiogenesis." Furthermore, he said that "the intestinal microvascularization of both CD and UC displays an activated profile as shown by the expression of angiogenic marker V3 integrin.

"Targeting this integrin could be a potential therapeutic approach for IBD," similar to approaches in other forms of chronic inflammation, Danese said. "These r
'"/>


13-Sep-2004


Page: 1 2 3

Related biology news :

1. Beware cancer, insomnia and liver disease UH students are taking aim
2. Purdue scientists: To stop cancer, keep your Icmt away from your Ras
3. Drug developed for rare disease may help millions more as treatment for cancer, autoimmune diseases
4. Telltale prostate cancer protein key to breast cancer, too
5. UGA receives $6.7 M grant that will add knowledge in fights against cancer, Parkinsons disease
6. Isolation of ferret protein promising for cancer, reproductive studies
7. UNC studies target molecular defects implicated in cancer, genetic diseases
8. Common human virus may be associated with colon cancer, according to Temple researchers
9. New technique widens the lens on cancer, could lead to new therapies
10. While some immune cells aim to fight cancer, others hold them in check
11. Amplified genome area mapped; New gene is overexpressed in oral cancer, say Pittsburgh researchers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/1/2019)... ... 2019 , ... The University of Vermont Health Network Ventures ... Series B Financing Round. , “With the commitment from the UVM fund ... and business resources to bear as we advance our biopharmaceutical products to the ...
(Date:5/31/2019)... , ... May 30, 2019 , ... ... in a live webinar on Wednesday, June 19, 2019 at ... operations teams, medical review teams, data management teams and contract research organizations (CROs) ...
(Date:5/26/2019)... , ... May 24, 2019 , ... Zolgensma (Novartis, AveXis), ... AVXS-101, was approved for clinical use in the United States by the Food and ... gene therapy approved to treat inherited genetic disorders in the United States and the ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 10, 2019 , ... Thought Technology ... the appointment of Biofeedback Tech Ltd as its authorised distributor for ... part of many therapeutic treatments and clinical assessment protocols to treat stress related ...
(Date:6/11/2019)... ... June 11, 2019 , ... A ... mesenchymal stem cells (MSC-EV) are able to incorporate into human CD34+ cells, modifying ... on mice, MSC-EVs also increased the cells’ ability to lodge into bone marrow. ...
(Date:5/31/2019)... ... May 30, 2019 , ... ... to announce the strategic acquisition of Metabiologics, Inc., a globally recognized leader in ... exclusive ownership and commercialization rights to a full spectrum of botulinum neurotoxins, as ...
(Date:5/15/2019)... ... May 16, 2019 , ... Emulsifiers are the magic bullet ... products rely on these ingredients to create stable quality food that can withstand ... shift triggers food formulators to seek out alternatives for starches, gums and chemical ...
Breaking Biology Technology:
Cached News: